Skip to main content

Pharmaceutical Marketing Factors in Testosterone Lawsuits

By April 14, 2015April 4th, 2022Pharmaceutical litigation, Testosterone

testosteronegellawsuitTwo men over 40 used testosterone gel, considering it a way to restore youthfulness. One man suffered a spinal stroke; the other man experienced a bilateral pulmonary embolism.

These two men―who shared their stories in a recent Forbes article―attribute their health problems to testosterone.

More and more health care providers and patients are becoming aware of these serious testosterone side effects, which also include heart attack and stroke.

The two men interviewed by Forbes didn’t suffer from hypogonadism, a medical condition that causes low testosterone levels; rather, these men fell prey to aggressive pharmaceutical marketing.

Ads promising the fountain of youth for older males drew these two men to testosterone gel, a lure that injured rather than restored.

To date, the U.S. Food and Drug Administration (FDA) hasn’t recognized low testosterone, or low T, in older males as a real medical condition warranting testosterone replacement therapy. The FDA has only approved testosterone use for patients diagnosed with hypogonadism.

Pharmaceutical marketing for testosterone gel aggressively targeted older men, persuading them to use a product for a health condition not even recognized by the FDA.

Clearly, in this case, pharmaceutical marketing went too far.

How We Can Help You

Carey Danis & Lowe is a law firm that represents men who suffered from testosterone gel. Our team of personal injury lawyers work tirelessly for these men in order to recover as many losses as possible.

We invite you to share your testosterone case with us; we offer free initial case evaluations where we guide you through you legal options, compensation eligibility, and how to file a testosterone lawsuit.

Contact Carey Danis & Lowe by phone at 800.721.2519, or complete a confidential personal injury claim form.